| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,061 |
17,632 |
$1.66M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,435 |
21,854 |
$1.41M |
| 95144 |
|
6,639 |
764 |
$805K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,553 |
4,129 |
$441K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,661 |
3,545 |
$337K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,816 |
11,745 |
$231K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,930 |
1,945 |
$210K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14,450 |
13,019 |
$180K |
| 96127 |
|
11,509 |
8,693 |
$165K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,841 |
2,058 |
$116K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,497 |
1,053 |
$97K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,737 |
2,741 |
$95K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,554 |
2,228 |
$90K |
| 96136 |
|
2,448 |
1,812 |
$84K |
| 90651 |
|
2,963 |
2,137 |
$78K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
932 |
865 |
$74K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,539 |
3,266 |
$72K |
| 99173 |
|
9,569 |
6,987 |
$70K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
617 |
512 |
$59K |
| 93000 |
|
2,586 |
1,995 |
$54K |
| 90620 |
|
2,616 |
1,908 |
$53K |
| 99384 |
|
536 |
363 |
$53K |
| 99383 |
|
562 |
432 |
$49K |
| 90734 |
|
2,559 |
1,706 |
$48K |
| 83655 |
|
4,114 |
2,763 |
$48K |
| 86580 |
|
8,164 |
5,754 |
$41K |
| 90686 |
|
3,885 |
3,121 |
$40K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
613 |
385 |
$34K |
| 90670 |
|
1,682 |
1,092 |
$31K |
| 0071A |
|
701 |
641 |
$29K |
| 90744 |
|
2,885 |
2,064 |
$29K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
343 |
242 |
$27K |
| 90633 |
|
2,556 |
1,680 |
$26K |
| 90715 |
|
1,833 |
1,244 |
$24K |
| 0072A |
|
572 |
556 |
$24K |
| 36416 |
|
6,162 |
4,208 |
$24K |
| 0001A |
|
502 |
459 |
$21K |
| 90710 |
|
1,400 |
901 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,458 |
887 |
$20K |
| 90649 |
|
953 |
631 |
$20K |
| 0002A |
|
417 |
397 |
$18K |
| 90619 |
|
989 |
747 |
$17K |
| 81025 |
|
3,581 |
2,673 |
$15K |
| 0124A |
|
360 |
280 |
$15K |
| 81003 |
|
5,876 |
4,588 |
$13K |
| 82962 |
|
6,745 |
4,816 |
$13K |
| 99385 |
|
114 |
66 |
$12K |
| 0004A |
|
292 |
227 |
$12K |
| 69209 |
|
1,381 |
853 |
$12K |
| 85018 |
|
4,902 |
3,366 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
249 |
227 |
$11K |
| 90688 |
|
1,252 |
812 |
$10K |
| 81002 |
|
3,853 |
2,993 |
$10K |
| 90756 |
|
501 |
374 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
351 |
318 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,749 |
5,074 |
$8K |
| 85014 |
|
3,258 |
2,274 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
150 |
108 |
$6K |
| 94760 |
|
1,510 |
1,421 |
$6K |
| 90698 |
|
595 |
378 |
$6K |
| 90696 |
|
524 |
327 |
$5K |
| 0154A |
|
115 |
94 |
$5K |
| D1206 |
Topical application of fluoride varnish |
183 |
81 |
$5K |
| 0073A |
|
108 |
87 |
$5K |
| 82947 |
|
1,139 |
807 |
$4K |
| 90700 |
|
413 |
281 |
$4K |
| 90716 |
|
275 |
192 |
$3K |
| 80305 |
|
363 |
243 |
$3K |
| 90713 |
|
246 |
174 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
298 |
201 |
$3K |
| 90677 |
|
69 |
52 |
$3K |
| 90680 |
|
335 |
219 |
$3K |
| 91320 |
|
63 |
43 |
$3K |
| 90461 |
|
3,034 |
2,240 |
$3K |
| 90707 |
|
200 |
142 |
$3K |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
1,119 |
646 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
53 |
34 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
25 |
21 |
$2K |
| 95117 |
|
216 |
187 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
33 |
29 |
$2K |
| 99382 |
|
18 |
13 |
$2K |
| 0081A |
|
37 |
28 |
$2K |
| 90648 |
|
190 |
119 |
$1K |
| 99406 |
|
181 |
119 |
$920.32 |
| 87634 |
|
13 |
12 |
$676.00 |
| 90697 |
|
23 |
13 |
$346.98 |
| 90656 |
|
20 |
15 |
$342.06 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,377 |
812 |
$148.76 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
321 |
254 |
$133.90 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
13 |
12 |
$25.45 |
| 99072 |
|
364 |
327 |
$20.00 |
| 91307 |
|
559 |
472 |
$1.06 |
| 91300 |
|
430 |
335 |
$0.98 |
| 91312 |
|
73 |
62 |
$0.14 |
| 91308 |
|
16 |
14 |
$0.04 |
| 94664 |
|
16 |
15 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
33 |
32 |
$0.00 |